IL6 and diabetes mellitus: Cases with an unfavorable treatment outcome had significantly higher concentrations of IL-6 at baseline relative to controls (0.26 log-higher concentration, 95%CI 0.17 to 0.36, p<0.001), after adjusting for markers of disease severity, pre-treatment illness duration, smoking status and diabetes.